These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9413091)

  • 81. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.
    Hu SL; Travis BM; Stallard V; Abrams K; Misher L; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1489-94. PubMed ID: 1466988
    [No Abstract]   [Full Text] [Related]  

  • 83. Protective effects against simian immunodeficiency virus agm (SIVagm) infection in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the SIVagm envelope gene.
    Ibuki K; Ido E; Funahashi S; Miura T; Hayami M; Shida H
    Vaccine; 1999 Oct; 18(5-6):511-6. PubMed ID: 10519941
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories.
    Hulskotte EG; Rimmelzwaan GF; Boes J; Bosch ML; Heeney JL; Norley SG; de Vries P; Osterhaus AD
    Vaccine; 1995 Sep; 13(13):1187-97. PubMed ID: 8578803
    [TBL] [Abstract][Full Text] [Related]  

  • 85. SIV and FIV vaccine studies at UC Davis: 1991 update.
    Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682
    [No Abstract]   [Full Text] [Related]  

  • 86. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.
    Letvin NL; Miller MD; Shen L; Chen ZW; Yasutomi Y
    Semin Immunol; 1993 Jun; 5(3):215-23. PubMed ID: 8394161
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine.
    Bahnemann HG
    Vaccine; 1990 Aug; 8(4):299-303. PubMed ID: 2204242
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins.
    Hulskotte EG; Dings ME; Norley SG; Osterhaus AD
    Vaccine; 1997 Dec; 15(17-18):1839-45. PubMed ID: 9413091
    [TBL] [Abstract][Full Text] [Related]  

  • 89.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 90.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.